The global continuous bladder irrigation devices market size is anticipated to reach USD 1.87 billion by 2030, expected to grow at a CAGR of 4.7% from 2023 to 2030. According to a new report by Grand View Research, Inc. The factors responsible for the market growth are an increase in the number of transurethral resections of the prostate (TURP) surgeries globally, a rise in the geriatric population, technological advancements, and increasing prevalence of urological disorders such as urinary tract infections (UTIs), prostate cancer, bladder cancer, and others. According to the American Cancer Society, in 2022, approximately 268,490 new cases of prostate cancer will be identified in the U.S., and 34,500 men will die from the disease.
Increased awareness among healthcare professionals and patients about the benefits of CBI in post-operative care and infection prevention contributes to market growth. For instance, in September 2022, the Urology Foundation organized Urology Awareness Month, which aims to increase public awareness of urological diseases and conditions as well as collect funds for essential research and training for healthcare professionals treating these conditions.
The prevalence of bladder-related conditions and procedures, like bladder tumor removal and transurethral resection of the prostate (TURP), is rising in aging population because aging people are more prone to these conditions, so there is a greater need for CBI devices. For instance, in January 2023, the American Cancer Society stated that about 9 out of 10 people with bladder cancer are over the age of 55, and the average age of people when they are diagnosed is 73.
Request a free sample copy or view report summary: Continuous Bladder Irrigation Devices Market Report
Based on product, the Foley 3-way catheters segment dominated the market in 2022 with a share of 54.40%. This growth can be attributed due to the three-way catheters can lead to cost savings in the long run and reducing the need for additional equipment and supplies related to irrigation.
The hospital segment held 53.14% of the overall end-user market in 2022. This growth can be attributed due to the hospitals having the necessary infrastructure, facilities, and resources to support the use of CBI devices. This includes sterile environments, trained staff, and access to a wide range of medical supplies and equipment.
North America dominated the overall regional market with the highest revenue share of 31.83% in 2022, owing to the developed healthcare systems in North American nations providing a wide range of urological services, such as diagnosis, therapy, and operations.
Grand View Research has segmented the global continuous bladder irrigation devices market on the basis of product, end-use, and region:
Continuous Bladder Irrigation Devices Product Outlook (Revenue, USD Million, 2018 - 2030)
Foley 3-way Catheters
Silicone Catheters
Latex Catheters
Accessories
Irrigation Set
Roller Clamp
Outlet Bags
Irrigation Bags
Continuous Bladder Irrigation Devices End-use Outlook (Revenue, USD Million, 2018 - 2030)
Long Term Care Facilities
Hospitals
Others
Continuous Bladder Irrigation Devices Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Norway
Denmark
Sweden
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Mexico
Argentina
Colombia
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the Continuous Bladder Irrigation Devices Market
Sterimed Group.
Angiplast pvt. ltd.
Advin Health Care
AdvaCare Pharma
Teleflex Incorporated
BACTIGUARD AB
VOGT MEDICAL
C. R. Bard (BD)
Coloplast
HEMC (Hospital Equipment Manufacturing Company)
Baxter Internationals
"The quality of research they have done for us has been excellent..."